元の名称記録: The Regents of the University of Michigan

The present disclosure relates to combination therapies for the treatment of cancer. In particular, the disclosure relates to combination therapy with a CXCR4 inhibitor and a taxane for the treatment of cancer. In some aspects, the disclosure relates to combination therapy with a CXCR4 inhibitor and a taxane for the treatment of tumors in the bone of a subject.

An organic photovoltaic (OPV) device comprises a first arrangement of at least one OPV cell, and a second arrangement of at least one OPV cell, wherein the first and second arrangements are connected in parallel. An organic photovoltaic device comprises a substrate, a first and second electrodes above the substrate, and a heterojunction between the electrodes, comprising a first and second regions, wherein at least a portion of the heterojunction is lightly doped, wherein a conductivity dopant is covalently tied to a host within the first or second regions.